ALXO
ALX Oncology Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.01
−0.99%Leverage
- Debt / equity
- 0.07x
- Net debt / equity
- -0.10x
- Debt / assets
- 0.06x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 0.16x
Liquidity & coverage
- Current ratio
- 9.71x
- Quick ratio
- 9.71x
- Cash ratio
- 9.35x
- Interest coverage
- -58.67x
- EBITDA / interest
- -56.10x
- Working capital
- $128.7M
Cash & dividend
- FCF / debt
- -7.31x
- Cash flow / debt
- -7.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026